Avenue Venture Opportunities Fund, L.P. 13D and 13G filings for Cytosorbents Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-28 6:47 pm Purchase |
2024-06-26 | 13G | Cytosorbents Corporation CTSO |
Avenue Venture Opportunities Fund, L.P. | 3,755,273 5.700% |
3,755,273 (New Position) |
Filing |